Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Johnson & Johnson To Sell Off Diagnostics Unit-Reuters

Tuesday, 22 Jan 2013 02:29pm EST 

Reuters reported that Johnson & Johnson may sell or spin off its slow-growing $2 billion-a-year diagnostics business, the Company said when it reported quarterly earnings. The diversified healthcare company said it may sell the Ortho Clinical Diagnostics business - whose products include equipment for laboratory diagnostics and blood transfusion screening - or turn it into a stand-alone company. 

Company Quote

0.31 +0.30%
24 Dec 2014